Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study

The treatment outcome of transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) varies greatly due to the clinical heterogeneity of the patients. Therefore, several prognostic systems have been proposed for risk stratification and candidate identification for first TAC...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2020-02, Vol.26 (6), p.657-669
Main Authors: Wang, Zhe-Xuan, Wang, En-Xin, Bai, Wei, Xia, Dong-Dong, Mu, Wei, Li, Jing, Yang, Qiao-Yi, Huang, Ming, Xu, Guo-Hui, Sun, Jun-Hui, Li, Hai-Liang, Zhao, Hui, Wu, Jian-Bing, Yang, Shu-Fa, Li, Jia-Ping, Li, Zi-Xiang, Zhang, Chun-Qing, Zhu, Xiao-Li, Zheng, Yan-Bo, Wang, Qiu-He, Yuan, Jie, Li, Xiao-Mei, Niu, Jing, Yin, Zhan-Xin, Xia, Jie-Lai, Fan, Dai-Ming, Han, Guo-Hong, On Behalf Of China Hcc-Tace Study Group
Format: Article
Language:English
Subjects:
Aged
alpha-Fetoproteins - analysis
Area Under Curve
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - therapy
Chemoembolization, Therapeutic - methods
Chemoembolization, Therapeutic - mortality
Clinical Decision Rules
Female
Humans
Liver Neoplasms - mortality
Liver Neoplasms - therapy
Male
Middle Aged
Prognosis
Retrospective Studies
Retrospective Study
Risk Assessment
Risk Factors
ROC Curve
Severity of Illness Index
Treatment Outcome
Tumor Burden
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The treatment outcome of transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) varies greatly due to the clinical heterogeneity of the patients. Therefore, several prognostic systems have been proposed for risk stratification and candidate identification for first TACE and repeated TACE (re-TACE). To investigate the correlations between prognostic systems and radiological response, compare the predictive abilities, and integrate them in sequence for outcome prediction. This nationwide multicenter retrospective cohort consisted of 1107 unresectable HCC patients in 15 Chinese tertiary hospitals from January 2010 to May 2016. The Hepatoma Arterial-embolization Prognostic (HAP) score system and its modified versions (mHAP, mHAP2 and mHAP3), as well as the six-and-twelve criteria were compared in terms of their correlations with radiological response and overall survival (OS) prediction for first TACE. The same analyses were conducted in 912 patients receiving re-TACE to evaluate the ART (assessment for re-treatment with TACE) and ABCR (alpha-fetoprotein, Barcelona Clinic Liver Cancer, Child-Pugh and Response) systems for post re-TACE survival (PRTS). All the prognostic systems were correlated with radiological response achieved by first TACE, and the six-and-twelve criteria exhibited the highest correlation (Spearman R = 0.39, = 0.026) and consistency (Kappa = 0.14, = 0.019), with optimal performance by area under the receiver operating characteristic curve of 0.71 [95% confidence interval (CI): 0.68-0.74]. With regard to the prediction of OS, the mHAP3 system identified patients with a favorable outcome with the highest concordance (C)-index of 0.60 (95%CI: 0.57-0.62) and the best area under the receiver operating characteristic curve at any time point during follow-up; whereas, PRTS was well-predicted by the ABCR system with a C-index of 0.61 (95%CI: 0.59-0.63), rather than ART. Finally, combining the mHAP3 and ABCR systems identified candidates suitable for TACE with an improved median PRTS of 36.6 mo, compared with non-candidates with a median PRTS of 20.0 mo (log-rank test < 0.001). Radiological response to TACE is closely associated with tumor burden, but superior prognostic prediction could be achieved with the combination of mHAP3 and ABCR in patients with unresectable liver-confined HCC.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v26.i6.657